Novel biphasic role of resolvin D1 on expression of cyclooxygenase-2 in LIPOPOLYSACCHARIDE-STIMULATED LUNG FIBROBLASTS IS PARTLY THROUGH PI3K/AKT and ERK2 pathways

22Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Fibroblasts, far frombeing merely bystander cells, are known to play a specific role in inflammation resolution after an acute injury. As the endogenous "braking signal," resolvins possess potent anti-inflammatory and proresolution actions. We demonstrated that the expression of COX-2 protein was significantly peaked initially at 6 hours but then also at 48 hours after LPS stimulation in lung fibroblasts. PGElevels also peaked at 6 hours, and PGDlevels were increased and peaked at 48 hours. However, no significant change in the protein expression of COX-1 was observed after treatment with LPS in lung fibroblasts. Exogenous resolvin D1 inhibited the first peak of COX-2 expression as well as the production of PGEinduced by LPS. In contrast, exogenous resolvin D1 increased the second peak of COX-2 expression as well as the production of PGDinduced by LPS. In addition, resolvin D1 inhibited COX-2 expression at 6 hours, which was partly through PI3K/AKT and ERK2 signalling pathways. © 2013 Derong Wu et al.

Cite

CITATION STYLE

APA

Wu, D., Zheng, S., Li, W., Yang, L., Liu, Y., Zheng, X., … Jin, S. (2013). Novel biphasic role of resolvin D1 on expression of cyclooxygenase-2 in LIPOPOLYSACCHARIDE-STIMULATED LUNG FIBROBLASTS IS PARTLY THROUGH PI3K/AKT and ERK2 pathways. Mediators of Inflammation, 2013. https://doi.org/10.1155/2013/964012

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free